Background: Epilepsy is genetically complex neurological disorder affecting millions of people of different age groups varying in its type and severity. Copy number variants (CNVs) are key players in the genetic etiology of numerous neurodevelopmental disorders and prior findings also revealed that chromosomal aberrations are more susceptible against the pathogenesis of epilepsy. Novel technologies, such as array comparative genomic hybridization (array-CGH), may help to uncover the pathogenic CNVs in patients with epilepsy. Results: This study was carried out by high density whole genome array-CGH analysis with blood DNA samples from a cohort of 22 epilepsy patients to search for CNVs associated with epilepsy. Pathogenic rearrangements whi...
Epilepsy is one of the most common neurological disorders in humans with a prevalence of 1% and a li...
Objective: To evaluate the diagnostic yield of microarray analysis in a hospital-based cohort of chi...
Copy number variants (CNV) are established risk factors for neurodevelopmental disorders with seizur...
Abstract Background Epilepsy is genetically complex but common brain disorder of the world affecting...
To perform an extensive search for genomic rearrangements by microarray-based comparative genomic hy...
OBJECTIVE: Copy number variations (CNVs) represent a significant genetic risk for several neurodevel...
Contains fulltext : 88500.pdf (publisher's version ) (Open Access)Epilepsy is one ...
Epilepsy is one of the most common neurological disorders in humans with a prevalence of 1% and a li...
Epilepsy will affect nearly 3% of people at some point during their lifetime. Previous copy number v...
Structural reorganization of chromosomes by genomic duplications and/or deletions are known as copy ...
<div><p>Epilepsy will affect nearly 3% of people at some point during their lifetime. Previous copy ...
Purpose: Copy number variants (CVNs), detected with chromosomal microarray, have been shown to cause...
AbstractBackgroundThe emergence of array comparative genomic hybridization (array CGH) as a diagnost...
Weset out to review the extent to which molecular karyotyping has overtaken conventional cytogenetic...
Copy number variants (CNV) are established risk factors for neurodevelopmental disorders with seizur...
Epilepsy is one of the most common neurological disorders in humans with a prevalence of 1% and a li...
Objective: To evaluate the diagnostic yield of microarray analysis in a hospital-based cohort of chi...
Copy number variants (CNV) are established risk factors for neurodevelopmental disorders with seizur...
Abstract Background Epilepsy is genetically complex but common brain disorder of the world affecting...
To perform an extensive search for genomic rearrangements by microarray-based comparative genomic hy...
OBJECTIVE: Copy number variations (CNVs) represent a significant genetic risk for several neurodevel...
Contains fulltext : 88500.pdf (publisher's version ) (Open Access)Epilepsy is one ...
Epilepsy is one of the most common neurological disorders in humans with a prevalence of 1% and a li...
Epilepsy will affect nearly 3% of people at some point during their lifetime. Previous copy number v...
Structural reorganization of chromosomes by genomic duplications and/or deletions are known as copy ...
<div><p>Epilepsy will affect nearly 3% of people at some point during their lifetime. Previous copy ...
Purpose: Copy number variants (CVNs), detected with chromosomal microarray, have been shown to cause...
AbstractBackgroundThe emergence of array comparative genomic hybridization (array CGH) as a diagnost...
Weset out to review the extent to which molecular karyotyping has overtaken conventional cytogenetic...
Copy number variants (CNV) are established risk factors for neurodevelopmental disorders with seizur...
Epilepsy is one of the most common neurological disorders in humans with a prevalence of 1% and a li...
Objective: To evaluate the diagnostic yield of microarray analysis in a hospital-based cohort of chi...
Copy number variants (CNV) are established risk factors for neurodevelopmental disorders with seizur...